Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
April 2021
The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs).
In a new perspective article in the Journal of Clinical Pathways, the National Pharmaceutical Council, Discern Health, and Drs. Mark McClellan and Ethan Basch draw from previous research on the use of PR-PMs in oncology to outline opportunities and recommendations for the Centers for Medicare & Medicaid Services to look beyond prior value-based payment models to accelerate appropriate use of PRMs and PR-PMs and elevate patient voices in future oncology value-based payment programs.